2013Transplantation and Cellular TherapyOpen access

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG

Sumiko Kohashi, Takehiko Mori, Jun Kato, Akiko Yamane, Shinichiro Okamoto

Open full text 0 citations

Abstract

Although allogeneic hematopoietic stem cell transplantation (HSCT) has been widely performed for severe aplastic anemia (SAA), the standard conditioning regimen has yet to be established. Recently, the outcomes of a variety of reduced-intensity conditioning regimens using fludarabine have been reported.

Open-access reader

About this research paper

What this paper is about

Although allogeneic hematopoietic stem cell transplantation (HSCT) has been widely performed for severe aplastic anemia (SAA), the standard conditioning regimen has yet to be established. Recently, the outcomes of a variety of reduced-intensity conditioning regimens using fludarabine have been reported.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Although allogeneic hematopoietic stem cell transplantation (HSCT) has been widely performed for severe aplastic anemia (SAA), the standard conditioning regimen has yet to be established. Recently, the outcomes of a variety of reduced-intensity conditioning regimens using fludarabine have been reported.

Key concepts: Medicine, Fludarabine, Thymoglobulin, Aplastic anemia, Cyclophosphamide, Transplantation, Hematopoietic stem cell transplantation, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using Fludarabine, Reduced-Dose Cyclophosphamide, and ATG — Research Paper | ScholarLens